Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1999 Jul;91(7):379–383.

Limitations in the use of race in the study of disease causation.

R S Cooper 1, V L Freeman 1
PMCID: PMC2608462  PMID: 10643209

Abstract

Tremendous variation exists in the rates of many chronic diseases across racial groups. However, serious technical and conceptual limitations hamper the ability of racial comparisons to illuminate the causative pathways. First, race is confounded by social class, which is complex, and like other confounders of race, may not be measured with equal validity across racial groups. Second, statistical "adjustments" for race effects can be misleading since residual confounding may be misconstrued as a genetic effect. Third, the biologic concept of race tempts us to ignore the context dependency of genetic expression. When trying to detect genetic effects, both the environmental and genetic contributions must be measured and potential gene-environment interactions accounted for. Unfortunately, this process is beyond our current technical capabilities. To move forward on the problem of prostate cancer and other diseases distinguished by marked ethnic differentials, investigators need a more comprehensive understanding of the factors that mediate the apparent effect of race combined with valid measures of those factors, as well as novel strategies that can help overcome the technical and interpretive limitations of statistical adjustment. Finally, the "grand" theories of race-based genetic susceptibility must be replaced with rigorous criteria to determine when a trait can be ascribed to some genetic origin.

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baquet C. R., Horm J. W., Gibbs T., Greenwald P. Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst. 1991 Apr 17;83(8):551–557. doi: 10.1093/jnci/83.8.551. [DOI] [PubMed] [Google Scholar]
  2. Brancati F. L., Whittle J. C., Whelton P. K., Seidler A. J., Klag M. J. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA. 1992 Dec 2;268(21):3079–3084. [PubMed] [Google Scholar]
  3. Coughlin S. S., Neaton J. D., Sengupta A., Kuller L. H. Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1994 Jan 15;139(2):166–172. doi: 10.1093/oxfordjournals.aje.a116978. [DOI] [PubMed] [Google Scholar]
  4. Huncharek M., Muscat J. Genetic characteristics of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):681–687. [PubMed] [Google Scholar]
  5. Kaufman J. S., Cooper R. S., McGee D. L. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology. 1997 Nov;8(6):621–628. [PubMed] [Google Scholar]
  6. Klahr S. The kidney in hypertension--villain and victim. N Engl J Med. 1989 Mar 16;320(11):731–733. doi: 10.1056/NEJM198903163201110. [DOI] [PubMed] [Google Scholar]
  7. Law M. R., Frost C. D., Wald N. J. By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. BMJ. 1991 Apr 6;302(6780):819–824. doi: 10.1136/bmj.302.6780.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Liberatos P., Link B. G., Kelsey J. L. The measurement of social class in epidemiology. Epidemiol Rev. 1988;10:87–121. doi: 10.1093/oxfordjournals.epirev.a036030. [DOI] [PubMed] [Google Scholar]
  9. Moore M. L., Michielutte R., Meis P. J., Ernest J. M., Wells H. B., Buescher P. A. Etiology of low-birthweight birth: a population-based study. Prev Med. 1994 Nov;23(6):793–799. doi: 10.1006/pmed.1994.1136. [DOI] [PubMed] [Google Scholar]
  10. Moul J. W., Douglas T. H., McCarthy W. F., McLeod D. G. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol. 1996 May;155(5):1667–1673. [PubMed] [Google Scholar]
  11. Schuler G. D., Boguski M. S., Stewart E. A., Stein L. D., Gyapay G., Rice K., White R. E., Rodriguez-Tomé P., Aggarwal A., Bajorek E. A gene map of the human genome. Science. 1996 Oct 25;274(5287):540–546. [PubMed] [Google Scholar]
  12. Wagenknecht L. E., Roseman J. M., Alexander W. J. Epidemiology of IDDM in black and white children in Jefferson County, Alabama, 1979-1985. Diabetes. 1989 May;38(5):629–633. doi: 10.2337/diab.38.5.629. [DOI] [PubMed] [Google Scholar]
  13. Whittemore A. S., Wu A. H., Kolonel L. N., John E. M., Gallagher R. P., Howe G. R., West D. W., Teh C. Z., Stamey T. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol. 1995 Apr 15;141(8):732–740. doi: 10.1093/oxfordjournals.aje.a117495. [DOI] [PubMed] [Google Scholar]
  14. Wild S., McKeigue P. Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ. 1997 Mar 8;314(7082):705–710. doi: 10.1136/bmj.314.7082.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Zahm S. H., Fraumeni J. F., Jr Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research. Environ Health Perspect. 1995 Nov;103 (Suppl 8):283–286. doi: 10.1289/ehp.95103s8283. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES